Paul E. Barré

12.9k total citations · 5 hit papers
90 papers, 9.6k citations indexed

About

Paul E. Barré is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Paul E. Barré has authored 90 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Nephrology, 22 papers in Cardiology and Cardiovascular Medicine and 13 papers in Surgery. Recurrent topics in Paul E. Barré's work include Dialysis and Renal Disease Management (38 papers), Cardiovascular Function and Risk Factors (11 papers) and Heart Failure Treatment and Management (10 papers). Paul E. Barré is often cited by papers focused on Dialysis and Renal Disease Management (38 papers), Cardiovascular Function and Risk Factors (11 papers) and Heart Failure Treatment and Management (10 papers). Paul E. Barré collaborates with scholars based in Canada, France and United States. Paul E. Barré's co-authors include John D. Harnett, Gloria M. Kent, Robert N. Foley, David C. Murray, Patrick S. Parfrey, Patrick S. Parfrey, J. Silberberg, Allan D. Sniderman, Sarah Prichard and Yitzchak M. Binik and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Pain.

In The Last Decade

Paul E. Barré

88 papers receiving 9.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1995 1.0k citations Robert N. Foley, Patrick S. Parfrey et al. Kidney International profile →
Impact of left ventricular hypertrophy on survival in end-stage renal disease

1989 641 citations Paul E. Barré, Allan D. Sniderman et al. Kidney International profile →
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease

1996 608 citations Robert N. Foley, Patrick S. Parfrey et al. American Journal of Kidney Diseases profile →
Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors

1995 549 citations John D. Harnett, Robert N. Foley et al. Kidney International profile →
Canadian Hemodialysis Morbidity Study

1992 449 citations David Churchill, D. Wayne Taylor et al. American Journal of Kidney Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul E. Barré Canada	43	6.2k	3.6k	1.7k	1.6k	1.3k	90	9.6k
Michael V. Rocco United States	51	6.4k 1.0×	1.9k 0.5×	1.0k 0.6×	2.0k 1.3×	1.4k 1.1×	165	9.4k
J. Michael Lazarus United States	62	10.0k 1.6×	2.1k 0.6×	1.7k 1.0×	2.9k 1.9×	2.6k 1.9×	200	14.9k
Peter G. Kerr Australia	53	6.2k 1.0×	1.3k 0.4×	987 0.6×	1.6k 1.0×	1.7k 1.3×	256	10.4k
Raymond M. Hakim United States	63	7.3k 1.2×	1.2k 0.3×	1.6k 1.0×	2.7k 1.7×	2.1k 1.6×	153	12.0k
David T. Gilbertson United States	48	4.4k 0.7×	1.4k 0.4×	1.2k 0.7×	1.9k 1.2×	1.5k 1.2×	180	10.2k
Annamaria T. Kausz United States	31	3.9k 0.6×	1.5k 0.4×	828 0.5×	1.2k 0.8×	1.4k 1.0×	43	8.0k
David A. Goodkin United States	36	6.2k 1.0×	785 0.2×	1.9k 1.1×	1.4k 0.9×	1.7k 1.3×	57	9.0k
Steven M. Brunelli United States	43	4.3k 0.7×	1.6k 0.4×	580 0.3×	1.7k 1.1×	1.4k 1.1×	135	7.5k
Edmund G. Lowrie United States	44	9.8k 1.6×	862 0.2×	1.5k 0.9×	2.7k 1.7×	1.4k 1.0×	78	12.1k
Jeroen P. Kooman Netherlands	51	6.0k 1.0×	1.9k 0.5×	588 0.3×	2.7k 1.7×	1.6k 1.2×	276	9.5k

Countries citing papers authored by Paul E. Barré

Since Specialization

Citations

This map shows the geographic impact of Paul E. Barré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Barré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Barré more than expected).

Fields of papers citing papers by Paul E. Barré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Barré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Barré. The network helps show where Paul E. Barré may publish in the future.

Co-authorship network of co-authors of Paul E. Barré

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Barré. A scholar is included among the top collaborators of Paul E. Barré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Barré. Paul E. Barré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mavrakanas, Thomas A., et al.. (2016). High Ultrafiltration Rates Increase Troponin Levels in Stable Hemodialysis Patients. American Journal of Nephrology. 43(3). 173–178. 11 indexed citations

Finkelstein, Fredric O., Kenneth Story, Catherine Firanek, et al.. (2008). Health-Related Quality of Life and Hemoglobin Levels in Chronic Kidney Disease Patients. Clinical Journal of the American Society of Nephrology. 4(1). 33–38. 135 indexed citations

Finkelstein, Fredric O., Kenneth Story, Catherine Firanek, et al.. (2008). Perceived knowledge among patients cared for by nephrologists about chronic kidney disease and end-stage renal disease therapies. Kidney International. 74(9). 1178–1184. 180 indexed citations

Podymow, Tiina, et al.. (2006). Tumoral calcinosis in a peritoneal dialysis patient. Kidney International. 70(11). 1887–1887. 6 indexed citations

Barré, Paul E., Helmut Reichel, Michael Suranyi, & Cláudia Barth. (2004). Efficacy of once-weekly epoetin alfa. Clinical Nephrology. 62(12). 440–448. 11 indexed citations

Devins, Gerald M., David C. Mendelssohn, Paul E. Barré, & Yitzchak M. Binik. (2003). Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. American Journal of Kidney Diseases. 42(4). 693–703. 158 indexed citations

Murphy, S., Robert N. Foley, Brendan J. Barrett, et al.. (2000). Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney International. 57(4). 1720–1726. 114 indexed citations

Foley, Robert N., Patrick S. Parfrey, Gloria M. Kent, et al.. (2000). Serial Change in Echocardiographic Parameters and Cardiac Failure in End-Stage Renal Disease. Journal of the American Society of Nephrology. 11(5). 912–916. 188 indexed citations

Foley, Robert N., Patrick S. Parfrey, Janet Morgan, et al.. (2000). Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney International. 58(3). 1325–1335. 318 indexed citations

10.

Devins, Gerald M., David J. Hollomby, Paul E. Barré, et al.. (2000). Long-Term Knowledge Retention following Predialysis Psychoeducational Intervention. The Nephron journals/Nephron journals. 86(2). 129–134. 31 indexed citations

11.

Éthier, Jean, R M Lindsay, Paul E. Barré, et al.. (1999). Clinical practice guidelines for vascular access. Canadian Society pf Nephrology.. PubMed. 10 Suppl 13. S297–305. 52 indexed citations

12.

Barrett, Brendan J., Patrick S. Parfrey, Janet Morgan, et al.. (1997). Prediction of early death in end-stage renal disease patients starting dialysis. American Journal of Kidney Diseases. 29(2). 214–222. 132 indexed citations

13.

Parfrey, Patrick S., Robert N. Foley, John D. Harnett, et al.. (1996). Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney International. 49(5). 1428–1434. 276 indexed citations

14.

Parfrey, Patrick S., John D. Harnett, Robert N. Foley, et al.. (1995). IMPACT OF RENAL TRANSPLANTATION ON UREMIC CARDIOMYOPATHY. Transplantation. 60(11). 908–913. 137 indexed citations

15.

Churchill, David, D. Wayne Taylor, Richard J. Cook, et al.. (1992). Canadian Hemodialysis Morbidity Study. American Journal of Kidney Diseases. 19(3). 214–234. 449 indexed citations breakdown →

16.

Caillon, J., et al.. (1989). Septicémie à Vibrio cholerae non 01.. La Presse Médicale. 18(17). 898–898. 2 indexed citations

17.

Barré, Paul E., et al.. (1989). [The symptom index: progress in the analysis of esophageal pH metry].. PubMed. 13(1). 32–7. 3 indexed citations

18.

Harnett, John D., Patrick S. Parfrey, Sheila M. Griffiths, et al.. (1988). Left Ventricular Hypertrophy in End-Stage Renal Disease. The Nephron journals/Nephron journals. 48(2). 107–115. 117 indexed citations

19.

Wolfe, L. S., et al.. (1985). Diagnostic Value of Kidney Biopsy in Heterozygous Fabry’s Disease. The Journal of Urology. 134(2). 435–435. 13 indexed citations

20.

Binik, Yitzchak M., Andrew G. Baker, Gerald M. Devins, et al.. (1982). Pain, control over treatment, and compliance in dialysis and transplant patients. Kidney International. 21(6). 840–848. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact